GGrantIndex
← Search

PHASE II STUDY OF RHIL 12 IV INJECTIONS IN ADVANCED MALIGNANT MELANOMA PATIENTS

$3,034M01FY2000RRNIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

View original record on NIH RePORTER →